Micardis and Ms contin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micardis (telmisartan) and Ms contin (morphine sulfate). Common drug interactions include rash among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Micardis and Ms contin. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

31 people who take Micardis and Ms contin together, and have interactions are studied.

Micardis and Ms contin drug interactions.

What are the common drug interactions of Micardis and Ms Contin, by gender? *:

female:

  1. Rash
  2. Pain in extremity
  3. Pneumonia
  4. Weight decreased
  5. Weight increased
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Arthralgia (joint pain)
  9. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  10. Blood creatinine increased

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Acute respiratory failure
  4. Anaemia (lack of blood)
  5. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  6. Blue toe syndrome (blue toe syndrome is a lack of blood flow to the toes causing a blue discoloration)
  7. Cancer pain
  8. Constipation
  9. Depressed mood
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

What are the common drug interactions of Micardis and Ms Contin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Weight increased
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
  3. Oedema peripheral (superficial swelling)
  4. Rash
  5. Swelling
  6. Chills (felling of cold)
  7. Disease recurrence
  8. Hyperhidrosis (abnormally increased sweating)
  9. Impaired driving ability
  10. Loss of employment

50-59:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Arthralgia (joint pain)
  3. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  4. Blood sodium decreased
  5. Joint swelling
  6. Pneumonia
  7. Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance)
  8. Rash
  9. Therapeutic response decreased (less preventive response)
  10. Thirst

60+:

  1. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  2. Renal impairment (severely reduced kidney function)
  3. Muscle spasms (muscle contraction)
  4. Nausea (feeling of having an urge to vomit)
  5. Pain in extremity
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Vomiting
  9. Abdominal distension
  10. Acute respiratory failure

What are the existing conditions these people have? *

  1. Constipation: 5 people, 16.13%
  2. Nausea (feeling of having an urge to vomit): 4 people, 12.90%
  3. High Blood Cholesterol: 4 people, 12.90%
  4. Stress And Anxiety: 4 people, 12.90%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 9.68%
  6. Breast Cancer: 3 people, 9.68%
  7. Depression: 3 people, 9.68%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.68%
  9. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 3 people, 9.68%
  10. Multiple Myeloma (cancer of the plasma cells): 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Micardis and Ms contin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Micardis and Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micardis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micardis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ms contin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on telmisartan and morphine sulfate (the active ingredients of Micardis and Ms contin, respectively), and Micardis and Ms contin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: